Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to assess the efficacy, tolerability and safety of oral administration of talampanel compared to a placebo in subjects with ALS.
Epistemonikos ID: 0285d2aa48e276b1b91f3ea16ddf2484ee417d1c
First added on: May 05, 2024